A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)
Phase: PHASE2 | Sponsor: Nathan Brashares Sackett | Compound: Psilocybin
- Status
- recruiting
- Institution
- Nathan Brashares Sackett
- Start date
- 2025-06-01
- End date
- 2026-06-01
- Registry ID
- NCT06853912
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.